CN Patent
CN107556289A — 一种氯苯‑吡啶类化合物及其应用
Assigned to TIANJIN INTERNATIONAL JOINT ACADEMY OF BIOMEDICINE · Expires 2018-01-09 · 8y expired
What this patent protects
本发明涉及一种氯苯‑吡啶类化合物及其应用,该类化合物可用于制备Smoothened蛋白抑制剂以及抗肠腺癌和食道癌的药物,具有如下通式(I)结构: 其中,X选自 或 R 1 选自H或 以及R 2 选自 或
USPTO Abstract
本发明涉及一种氯苯‑吡啶类化合物及其应用,该类化合物可用于制备Smoothened蛋白抑制剂以及抗肠腺癌和食道癌的药物,具有如下通式(I)结构: 其中,X选自 或 R 1 选自H或 以及R 2 选自 或
Drugs covered by this patent
- Erivedge (vismodegib) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.